Patients with higher baseline neutrophil counts or high tumor expression of CSF3 (G-CSF), the growth factor for neutrophils, especially benefit from Avastin in a large exploratory cohort and two clinical trial cohorts.
Click here for abstract and full text links.
No comments:
Post a Comment